Biomarker Decision Board is the practical layer between broad biomarker reading and protocol execution. It answers which panel to open first, which signal is more actionable, how often to repeat it and when the cost is justified.
Signal first
The board reduces the first move to objective, panel depth, repeat window and actionability so the next decision stays grounded.
Fast routes
Use the board to choose the next useful panel, then drop into blood markers, the science shelf or stack analysis without widening the scope too early.
Scope rule
Decision lanes
Practical biomarker objectives
High-action lanes
Worth acting on early
Low-cost starts
Cheaper first passes
Medium-cost labs
Panels that need more selective timing
Objective
Do not open the widest panel first. Start from cardiometabolic risk, glycemic control, fatigue, recovery or safety.
Panel
A compact baseline usually beats an expensive maximal panel with no plan for repetition.
Timing
Most markers need weeks, not days, before you can read intervention effects without fooling yourself.
Return to the broader biomarker reading layer when you need a cleaner public-facing overview.
Go deeper into blood markers when the next move is lipid, glucose or inflammation interpretation.
Check the evidence shelf before widening the panel or adding new interventions.
Move into practical intervention fit once the objective and first biomarker lane are already clear.
Move into compounds, timing and interaction risk after the biomarker lane is clearer.
Search by objective, marker or panel
Search by topic or category.
6 visible results
Cardiometabolic risk
Family history, unclear LDL or ApoB, or a first serious longevity baseline.
Glycemic control and energy
Energy swings, difficult appetite control, central adiposity or uncertainty around glucose tolerance.
Inflammation and recovery
Poor recovery, persistent soreness, inflammatory suspicion or signs of overreaching.
Nutrient gaps and fatigue
Fatigue, restrictive diets, high training volume or long-term blind supplementation.
Thyroid and adaptation
Persistent fatigue, cold intolerance, weight shifts or unclear adaptation despite decent sleep and food.
Liver and kidney tolerance
Long stacks, hepatically loaded compounds, high creatine intake or uncertainty around real tolerance.
| Objective | First panel and markers | Frequency | Actionability and cost | Timing and caution |
|---|---|---|---|---|
| Cardiometabolic risk Family history, unclear LDL or ApoB, or a first serious longevity baseline. | Baseline lipid and inflammation panel
| Baseline, 8-12 weeks after a serious change, then every 6-12 months when stable | Very high Medium | Repeat when diet, bodyweight, medication or training have had time to settle. Do not overreact to a single high hs-CRP or to a non-comparable fasting panel. |
| Glycemic control and energy Energy swings, difficult appetite control, central adiposity or uncertainty around glucose tolerance. | Baseline glucose plus an integrated marker
| 12 weeks for HbA1c; 2-4 weeks for a CGM block | Very high Low-medium | Judge HbA1c over full biological windows; use CGM for specific weeks, not forever. A CGM without sleep, meal and training logs creates a lot of noise chasing. |
| Inflammation and recovery Poor recovery, persistent soreness, inflammatory suspicion or signs of overreaching. | Context-aware inflammation snapshot
| 6-8 weeks after illness, overload or a protocol change | Medium Low | Do not test in the middle of an acute infection or right after an extreme training week unless that is the issue. An isolated CRP without clinical or load context rarely decides much on its own. |
| Nutrient gaps and fatigue Fatigue, restrictive diets, high training volume or long-term blind supplementation. | Micronutrients and functional anemia check
| 8-12 weeks after supplementation; 2-3 times per year if stable | Mid-high Medium | Measure before expanding the stack and repeat after one stable correction window. A normal serum marker does not always invalidate symptoms or absorption context. |
| Thyroid and adaptation Persistent fatigue, cold intolerance, weight shifts or unclear adaptation despite decent sleep and food. | Basic thyroid panel with escalation only when needed
| 8-12 weeks after dose or lifestyle changes; then symptom-led | Medium Medium | Do not chase week-to-week oscillations: thyroid needs sleep, calorie and load context. Interpreting thyroid outside symptoms and energy context often leads to overfitting. |
| Liver and kidney tolerance Long stacks, hepatically loaded compounds, high creatine intake or uncertainty around real tolerance. | Tolerance panel for stacks and medications
| Baseline and 6-12 weeks after adding new load or combining compounds | High Medium | Repeat after a stable block of supplementation or training, not the day after an extreme session. High creatinine in muscular users or high creatine intake does not automatically mean kidney damage. |
Cardiometabolic risk
First markers
Best when: Family history, unclear LDL or ApoB, or a first serious longevity baseline.
Frequency: Baseline, 8-12 weeks after a serious change, then every 6-12 months when stable
Timing note: Repeat when diet, bodyweight, medication or training have had time to settle.
Caution: Do not overreact to a single high hs-CRP or to a non-comparable fasting panel.
Glycemic control and energy
First markers
Best when: Energy swings, difficult appetite control, central adiposity or uncertainty around glucose tolerance.
Frequency: 12 weeks for HbA1c; 2-4 weeks for a CGM block
Timing note: Judge HbA1c over full biological windows; use CGM for specific weeks, not forever.
Caution: A CGM without sleep, meal and training logs creates a lot of noise chasing.
Inflammation and recovery
First markers
Best when: Poor recovery, persistent soreness, inflammatory suspicion or signs of overreaching.
Frequency: 6-8 weeks after illness, overload or a protocol change
Timing note: Do not test in the middle of an acute infection or right after an extreme training week unless that is the issue.
Caution: An isolated CRP without clinical or load context rarely decides much on its own.
Nutrient gaps and fatigue
First markers
Best when: Fatigue, restrictive diets, high training volume or long-term blind supplementation.
Frequency: 8-12 weeks after supplementation; 2-3 times per year if stable
Timing note: Measure before expanding the stack and repeat after one stable correction window.
Caution: A normal serum marker does not always invalidate symptoms or absorption context.
Thyroid and adaptation
First markers
Best when: Persistent fatigue, cold intolerance, weight shifts or unclear adaptation despite decent sleep and food.
Frequency: 8-12 weeks after dose or lifestyle changes; then symptom-led
Timing note: Do not chase week-to-week oscillations: thyroid needs sleep, calorie and load context.
Caution: Interpreting thyroid outside symptoms and energy context often leads to overfitting.
Liver and kidney tolerance
First markers
Best when: Long stacks, hepatically loaded compounds, high creatine intake or uncertainty around real tolerance.
Frequency: Baseline and 6-12 weeks after adding new load or combining compounds
Timing note: Repeat after a stable block of supplementation or training, not the day after an extreme session.
Caution: High creatinine in muscular users or high creatine intake does not automatically mean kidney damage.